Myeloma in Scar Tissue - An Underreported Phenomenon or an Emerging Entity in the Novel Agents' Era? A Single Center Series
- 10 January 2014
- journal article
- case report
- Published by S. Karger AG in Acta Haematologica
- Vol. 132 (1), 39-44
- https://doi.org/10.1159/000354830
Abstract
Tumor relapse in scar tissue is uncommon in cancer patients. Likewise, extramedullary plasmacytoma (EMP) relapse in scar tissue in the setting of multiple myeloma (MM) has been rarely reported. We report a series of 3 patients whose disease progressed as EMP at the site of a wound from previous invasive procedures. All 3 patients were treated for the relapsed disease with different treatment modalities, but failed to respond adequately and died several months after relapse. At original MM diagnosis, all had advanced-stage disease. They were treated with novel agents with or without autologous hematopoietic stem cell transplantation and achieved either a complete or very good partial response. We suggest that these treatments, which have become the standard of care in MM, may permit a predominance of myeloma subclones which are independent of the bone marrow microenvironment. These myeloma subclones then gain a survival advantage in the active scar-tissue niche, allowing for their uncontrolled proliferation. This case series might represent an underreported phenomenon and therefore may indicate an emerging and difficult-to-treat disease in the era of targeted therapies in MM. Physicians treating MM should be aware of this phenomenon, especially when referring their patients for invasive procedures.Keywords
This publication has 25 references indexed in Scilit:
- Extensive soft‐tissue involvement by plasmablastic myeloma arising from displaced humeral fracturesEuropean Journal of Haematology, 2010
- Recurrence of B-cell lymphoma within an implantable cardioverter defibrillator wound scarEP Europace, 2010
- TGF-β-related mechanisms of bone destruction in multiple myelomaBone, 2010
- Clinicopathological features of extramedullary recurrence/relapse of multiple myelomaEuropean Journal of Haematology, 2008
- International uniform response criteria for multiple myelomaLeukemia, 2006
- Extramedullary disease and targeted therapies for hematological malignancies—is the association real?Annals Of Oncology, 2006
- Drug Insight: thalidomide as a treatment for multiple myelomaNature Clinical Practice Oncology, 2005
- Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcomeBone Marrow Transplantation, 2004
- Subcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplantAmerican Journal of Hematology, 2003
- Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantationBone Marrow Transplantation, 2000